Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Mar;35(3):e21.
doi: 10.2337/dc11-2306.

Metformin-induced hepatotoxicity

Francisco Miralles-Linares, Susana Puerta-Fernandez, M Rosa Bernal-Lopez, Francisco J Tinahones, Raul J Andrade, Ricardo Gomez-Huelgas
Case Reports

Metformin-induced hepatotoxicity

Francisco Miralles-Linares et al. Diabetes Care. 2012 Mar.
No abstract available

PubMed Disclaimer

References

    1. Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother 2010;44:1655–1659 - PubMed
    1. Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323–1330 - PubMed
    1. Romero-Gómez M, Diago M, Andrade RJ, et al. ; Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009;50:1702–1708 - PubMed
    1. Brackett CC. Clarifying metformin's role and risks in liver dysfunction. J Am Pharm Assoc (2003) 2010;50:407–410 - PubMed
    1. Rhee MK, Herrick K, Ziemer DC, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33:49–54 - PMC - PubMed